Echinacea

DRUG6 trials

Sponsors

National Center for Complementary and Integrative Health (NCCIH), University of Wisconsin, Madison, A. Vogel AG, Germans Trias i Pujol Hospital, Hormozgan University of Medical Sciences

Conditions

Common ColdHIV InfectionsInfectionsUpper Respiratory Tract Infections

Phase 2

Evaluation of Echinacea for the Common Cold

CompletedNCT00032500

National Center for Complementary and Integrative Health (NCCIH)Common Cold

Start: 2001-09-30End: 2004-05-31Updated: 2006-08-18

Phase 3

A Trial of Echinacea in Children

CompletedNCT00029211

National Center for Complementary and Integrative Health (NCCIH)Common Cold

Start: 2000-04-30End: 2003-03-31Target: 600Updated: 2006-08-18

Echinacea Versus Placebo Effect in Common Cold (Physician Echinacea Placebo)

CompletedNCT00065715

University of Wisconsin, MadisonCommon Cold

Start: 2003-09-30End: 2013-04-30Updated: 2014-12-04

Phase 4

Echinacea Safety Study

CompletedNCT01021995

A. Vogel AGInfections

Start: 2009-10-31End: 2011-04-30Updated: 2014-07-23

Drug Interactions Between Echinacea Purpurea and Darunavir/Ritonavir

CompletedNCT01046890

Germans Trias i Pujol HospitalHIV Infections

Start: 2010-01-31End: 2010-04-30Updated: 2019-12-04

Unknown Phase

Impact of Echinacea as Prophilaxis for Upper Respiratory Tract Infections in Children 1-5 Years

CompletedNCT01396889

Hormozgan University of Medical SciencesUpper Respiratory Tract Infections

Start: 2010-05-31End: 2011-07-31Updated: 2011-07-22

Related Papers

Echinacea for treating the common cold: a randomized trial.

2010-12-0155 citations